LINE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lineage Inc is not a strong buy for a beginner long-term investor at this moment. The stock lacks clear positive catalysts, faces legal challenges, and has weak financial performance. While analysts have mixed views, the lack of proprietary trading signals and the ongoing legal investigation suggest caution.
The technical indicators are neutral. MACD is positive but contracting, RSI is neutral at 44.762, and moving averages are converging. The stock is trading below the pivot level of 36.103, with key support at 34.282 and resistance at 37.923.
Some analysts, such as Goldman Sachs and Compass Point, see potential for growth in 2027-2028 due to easier comps and stabilization in the operating environment. Gross margin increased YoY in Q4 2025.
Ongoing legal investigation by Kuehn Law for alleged financial misrepresentation. Hedge funds are selling heavily, with a 379.67% increase in selling last quarter. Financial performance in Q4 2025 showed significant declines in revenue, net income, and EPS. Analysts have mixed ratings, with several maintaining Neutral or Sector Perform ratings.
In Q4 2025, revenue dropped by -0.22% YoY to $1.336 billion. Net income fell drastically by -108% YoY to $6 million, and EPS dropped by -109.09% YoY to $0.03. However, gross margin improved slightly to 15.04%, up 2.24% YoY.
Analysts have mixed ratings. Goldman Sachs and Compass Point are optimistic with Buy ratings and price targets of $51 and $47, respectively. However, Piper Sandler, Citi, and Scotiabank maintain Neutral or Sector Perform ratings, with price targets ranging from $35 to $44. Analysts highlight stabilization but also note macroeconomic uncertainties and soft consumer demand.
